NO940590L - Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstid - Google Patents
Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstidInfo
- Publication number
- NO940590L NO940590L NO940590A NO940590A NO940590L NO 940590 L NO940590 L NO 940590L NO 940590 A NO940590 A NO 940590A NO 940590 A NO940590 A NO 940590A NO 940590 L NO940590 L NO 940590L
- Authority
- NO
- Norway
- Prior art keywords
- short
- benzodiazepines
- benzodiazepine
- lives
- transdermal administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/750,571 US5225198A (en) | 1991-08-27 | 1991-08-27 | Transdermal administration of short or intermediate half-life benzodiazepines |
PCT/US1992/007033 WO1993003694A1 (en) | 1991-08-27 | 1992-08-19 | Transdermal administration of short or intermediate half-life benzodiazepines |
Publications (2)
Publication Number | Publication Date |
---|---|
NO940590L true NO940590L (no) | 1994-02-21 |
NO940590D0 NO940590D0 (no) | 1994-02-21 |
Family
ID=25018394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940590A NO940590D0 (no) | 1991-08-27 | 1994-02-21 | Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstid |
Country Status (10)
Country | Link |
---|---|
US (2) | US5225198A (de) |
EP (1) | EP0621769A4 (de) |
JP (1) | JPH06510049A (de) |
AU (1) | AU654875B2 (de) |
CA (1) | CA2115841A1 (de) |
FI (1) | FI940948A (de) |
NO (1) | NO940590D0 (de) |
NZ (1) | NZ244065A (de) |
PT (1) | PT100815A (de) |
WO (1) | WO1993003694A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225198A (en) * | 1991-08-27 | 1993-07-06 | Cygnus Therapeutic Systems | Transdermal administration of short or intermediate half-life benzodiazepines |
US5229130A (en) * | 1991-12-20 | 1993-07-20 | Cygnus Therapeutics Systems | Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
AU6410494A (en) * | 1993-03-17 | 1994-10-11 | Alza Corporation | Device for the transdermal administration of alprazolam |
US5635204A (en) * | 1994-03-04 | 1997-06-03 | Montefiore Medical Center | Method for transdermal induction of anesthesia, analgesia or sedation |
US5552153A (en) * | 1994-04-28 | 1996-09-03 | Hoffman-La Roche Inc. | Pharmaceutical composition for transdermal delivery |
US5580574A (en) * | 1994-04-28 | 1996-12-03 | Hoffmann-La Roche Inc. | Pharmaceutical composition for transdermal delivery |
US5635203A (en) * | 1994-09-29 | 1997-06-03 | Alza Corporation | Transdermal device having decreased delamination |
US6024974A (en) * | 1995-01-06 | 2000-02-15 | Noven Pharmaceuticals, Inc. | Composition and methods for transdermal delivery of acid labile drugs |
JPH11506744A (ja) | 1995-06-07 | 1999-06-15 | ノウブン ファーマシューティカルズ インク. | 室温で液体である低分子量薬を含む経皮組成物 |
US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
US5891461A (en) * | 1995-09-14 | 1999-04-06 | Cygnus, Inc. | Transdermal administration of olanzapine |
IT1294748B1 (it) | 1997-09-17 | 1999-04-12 | Permatec Tech Ag | Formulazione per un dispositivo transdermico |
DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
US6599532B2 (en) * | 2000-01-13 | 2003-07-29 | Osmotica Corp. | Osmotic device containing alprazolam and an antipsychotic agent |
DE10041478A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
US20030026830A1 (en) * | 2001-05-08 | 2003-02-06 | Thomas Lauterback | Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
US20030027793A1 (en) * | 2001-05-08 | 2003-02-06 | Thomas Lauterback | Transdermal treatment of parkinson's disease |
EP1258257A3 (de) * | 2001-05-15 | 2003-09-24 | IVF Hartmann AG | Hautpflegende Klebstoffzusammensetzung |
DE10234673B4 (de) * | 2002-07-30 | 2007-08-16 | Schwarz Pharma Ag | Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren |
US8246979B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system for the administration of rotigotine |
US8246980B2 (en) | 2002-07-30 | 2012-08-21 | Ucb Pharma Gmbh | Transdermal delivery system |
US8211462B2 (en) * | 2002-07-30 | 2012-07-03 | Ucb Pharma Gmbh | Hot-melt TTS for administering rotigotine |
DK1426049T3 (da) * | 2002-12-02 | 2005-08-22 | Sanol Arznei Schwarz Gmbh | Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom |
DE10261696A1 (de) * | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
CN100402036C (zh) * | 2004-04-26 | 2008-07-16 | 袁重华 | 治疗失眠的涂敷剂 |
US20070087055A1 (en) * | 2005-10-14 | 2007-04-19 | David Jan | Directly compressible extended release alprazolam formulation |
WO2009086137A1 (en) * | 2007-12-21 | 2009-07-09 | Zars Pharma, Inc. | Patches, formulations, and associated methods for transdermal delivery of alprazolam and other drugs |
US10449201B2 (en) * | 2015-08-17 | 2019-10-22 | Alpha To Omega Pharmaceutical Consultants, Inc. | Transdermal and/or topical delivery system comprising clobazam |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3987052A (en) * | 1969-03-17 | 1976-10-19 | The Upjohn Company | 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
US4557934A (en) * | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
JPS6133129A (ja) * | 1984-07-25 | 1986-02-17 | Nitto Electric Ind Co Ltd | 基剤組成物および外用医薬組成物 |
JPS61254519A (ja) * | 1985-05-07 | 1986-11-12 | Nitto Electric Ind Co Ltd | ゲル状医薬製剤 |
US4863738A (en) * | 1987-11-23 | 1989-09-05 | Alza Corporation | Skin permeation enhancer compositions using glycerol monooleate |
US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
US5252335A (en) * | 1989-07-12 | 1993-10-12 | Cygnus Therapeutic Systems | Transdermal administration of lisuride |
US5225198A (en) * | 1991-08-27 | 1993-07-06 | Cygnus Therapeutic Systems | Transdermal administration of short or intermediate half-life benzodiazepines |
-
1991
- 1991-08-27 US US07/750,571 patent/US5225198A/en not_active Expired - Lifetime
-
1992
- 1992-08-19 CA CA002115841A patent/CA2115841A1/en not_active Abandoned
- 1992-08-19 JP JP5504589A patent/JPH06510049A/ja active Pending
- 1992-08-19 EP EP92918256A patent/EP0621769A4/de not_active Withdrawn
- 1992-08-19 WO PCT/US1992/007033 patent/WO1993003694A1/en not_active Application Discontinuation
- 1992-08-19 AU AU24880/92A patent/AU654875B2/en not_active Ceased
- 1992-08-24 NZ NZ244065A patent/NZ244065A/en unknown
- 1992-08-26 PT PT100815A patent/PT100815A/pt not_active Application Discontinuation
-
1993
- 1993-06-28 US US08/083,676 patent/US5378473A/en not_active Expired - Lifetime
-
1994
- 1994-02-21 NO NO940590A patent/NO940590D0/no unknown
- 1994-02-28 FI FI940948A patent/FI940948A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US5225198A (en) | 1993-07-06 |
EP0621769A4 (de) | 1995-06-07 |
JPH06510049A (ja) | 1994-11-10 |
FI940948A0 (fi) | 1994-02-28 |
CA2115841A1 (en) | 1993-03-04 |
AU654875B2 (en) | 1994-11-24 |
US5378473A (en) | 1995-01-03 |
PT100815A (pt) | 1993-09-30 |
WO1993003694A1 (en) | 1993-03-04 |
FI940948A (fi) | 1994-02-28 |
AU2488092A (en) | 1993-03-16 |
EP0621769A1 (de) | 1994-11-02 |
NO940590D0 (no) | 1994-02-21 |
NZ244065A (en) | 1995-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO940590L (no) | Transdermal administrering av benzodiazepiner med kort eller mellomlang halveringstid | |
ATA87488A (de) | Mehrschichtiges transdermales therapeutisches system fuer die kombinierte applikation von oestrogen bzw. synthetischen oestrogen-wirksamen verbindungen mit synthetischen gestagenen | |
DE3161605D1 (en) | Therapeutic system for administering drugs to the skin | |
CA2064687A1 (en) | Method and device for administering dexmedetomidine transdermaly | |
EP0196769A3 (en) | A novel transdermal pharmaceutical absorption dosage unit | |
GB2156215B (en) | Percutaneous absorption type adhesive pharmaceutical preparation | |
ZA951427B (en) | Drug containing adhesive composite transdermal delivery device | |
NO895172D0 (no) | Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff. | |
ATE109357T1 (de) | Transdermales estradiol als therapeutisches sytem. | |
IL106512A (en) | Plaster for the transdermal application of steroid hormones and process for the preparation thereof | |
NO952908D0 (no) | Nitroglycerolholdig plaster, fremgangsmåte for fremstilling, samt anvendelse av plasteret | |
GR1002079B (en) | System of a special structure and composition for the rapid transdermal administration of oestrogens. | |
EP0235259A4 (de) | Transdermale arzneimitteleinzeldosis gegen angina und verfahren zu ihrer verabreichung. | |
PL308531A1 (en) | Percutaneous therapeutic system for applying physostygmine onto skin and method of obtaining same | |
PL319013A1 (en) | Transdermal therapeutic system containing estradiol and water bonding additives | |
DE59509643D1 (de) | Transdermales therapeutisches system mit hydrolyseschutz | |
NO924926L (no) | Transdermal administrering av buprenorfin | |
TW273516B (en) | Adhesive matrix-type transdermal therapeutic set for motion sickness |